Cargando…
Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology
While immunotherapy for pediatric cancer has made great strides in recent decades, including the FDA approval of agents such as dinutuximab and tisgenlecleucel, these successes have rarely impacted children with pediatric central nervous system (CNS) tumors. As our understanding of the biological un...
Autores principales: | Foster, Jessica B., Alonso, Marta M., Sayour, Elias, Davidson, Tom B., Persson, Mika L., Dun, Matthew D., Kline, Cassie, Mueller, Sabine, Vitanza, Nicholas A., van der Lugt, Jasper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232854/ https://www.ncbi.nlm.nih.gov/pubmed/37244226 http://dx.doi.org/10.1016/j.neo.2023.100909 |
Ejemplares similares
-
Current state of pediatric neuro-oncology imaging, challenges and future directions
por: Nabavizadeh, Ali, et al.
Publicado: (2023) -
Retrospective dataset and survey analyses identify gaps in data collection for craniopharyngioma and priorities of patients and families affected by the disease
por: Marshall, Emily, et al.
Publicado: (2023) -
Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagement
por: Waanders, Angela, et al.
Publicado: (2023) -
Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety
por: Vitanza, Nicholas A., et al.
Publicado: (2023) -
Interdisciplinary care of children with diffuse midline glioma
por: Coleman, Christina, et al.
Publicado: (2022)